# Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

> clinical trial · VERIFIED · 2026-06-30

Status: RECRUITING · Sponsor: Corcept Therapeutics · Condition: Neoplasms

- Company: Corcept Therapeutics
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07276373

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.